Dow Up 0.36% Nasdaq Up 0.12%

CytRx Corporation (CYTR)

-NCM
3.18 0.00(0.00%) 4:00PM EDT
|After Hours : 3.18 0.00 (0.00%) 4:00PM EDT - Nasdaq Real Time Price
Prev Close:3.18
Open:3.18
Bid:3.17 x 6700
Ask:3.18 x 5800
1y Target Est:11.00
Beta:1.37
Next Earnings Date:N/A
Day's Range:3.09 - 3.25
52wk Range:2.00 - 8.35
Volume:492,660
Avg Vol (3m):1,443,370
Market Cap:177.29M
P/E (ttm):N/A
EPS (ttm):-0.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTR

Comparison

Symbol% ChgMkt Cap
CYTR 0.00%177.29M
LLYUp 0.03%66.48B
NVSUp 0.40%215.81B
SNYUp 1.80%141.03B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,772.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.70
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback